The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allergan plc

NYSE: AGN
Last

(U.S.) $280.48

Today's change+5.93 +2.16%
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.
 

Allergan plc

NYSE: AGN
Last

(U.S.) $280.48

Today's change+5.93 +2.16%
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.

Allergan plc up sharply

Allergan plc closed up sharply Friday, rallying (U.S.)$5.93 or 2.16% to (U.S.)$280.48. Over the last five days, shares have gained 2.44%, but are down 10.25% for the last year to date. Shares have outperformed the S&P 500 by 10.29% during the last year.

Key company metrics

  • Open(U.S.) $277.30
  • Previous close(U.S.) $274.55
  • High(U.S.) $280.48
  • Low(U.S.) $272.23
  • Bid / Ask-- / --
  • YTD % change-10.25%
  • Volume2,726,908
  • Average volume (10-day)2,777,968
  • Average volume (1-month)2,704,717
  • Average volume (3-month)4,056,162
  • 52-week range(U.S.) $237.50 to (U.S.) $340.34
  • Beta0.78
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward18.18×
  • Forward PEG2.12×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$8.67
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-18.97%

Allergan plc has a net profit margin of -18.97%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue4,0895,7554,2344,057
Total other revenue--------
Total revenue4,0895,7554,2344,057
Gross profit2,8463,6252,5212,226
Total cost of revenue1,2432,1301,7131,831
Total operating expense5,4325,9704,5564,682
Selling / general / administrative1,0731,4611,4291,198
Research & development1,561653431468
Depreciation / amortization1,5601,674925877
Interest expense (income), net operating--------
Unusual expense (income)-45358308
Other operating expenses, total--------
Operating income-1,344-215-322-625
Interest income (expense), net non-operating-340-340-172-128
Gain (loss) on sale of assets5------
Other--------
Income before tax-1,680-549-690-795
Income after tax-855-242-512-733
Income tax, total-825-307-178-62
Net income5,301-243-512-733
Total adjustments to net income-70-70-23--
Net income before extra. items-856-243-512-733
Minority interest-1-200
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-926-313-535-733
Inc. avail. to common incl. extra. items5,232-313-535-733
Diluted net income5,232-313-535-733
Dilution adjustment0--0--
Diluted weighted average shares394393290266
Diluted EPS excluding extraordinary itemsvalue per share-2.35-0.80-1.85-2.76
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-2.37-0.71-1.72-2.00